Five-year experience with levamisole in cancer patients.
D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*
D007978:Levamisole